NCT01493986View on ClinicalTrials.gov

Minimum Effective Volume of Ropivacaine 7.5 mg/ml for the Lateral and Sagittal Infraclavicular Brachial Plexus Block

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

July 31, 2012

Conditions
Pain
Interventions
DRUG

Ropivacaine

Dosage. Onset time

Trial Locations (1)

9038

University Hospital of North Norway, Tromsø

All Listed Sponsors
lead

University Hospital of North Norway

OTHER

NCT01493986 - Minimum Effective Volume of Ropivacaine 7.5 mg/ml for the Lateral and Sagittal Infraclavicular Brachial Plexus Block | Biotech Hunter | Biotech Hunter